B. P. Morgan

Tissue-Specific Host Recognition by Complement Factor H Is Mediated by Differential Activities of Its Glycosaminoglycan-Binding Regions

D. Uhrín, Simon J. Clark, B. Morgan, 2013, The Journal of Immunology.

Complement in multiple sclerosis: its role in disease and potential as a biomarker

G. Ingram, B. Morgan, S. Hakobyan, 2009, Clinical and experimental immunology.

Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder

K. Harding, S. Hakobyan, S. Luppe, 2017, Multiple sclerosis.

Elevated plasma C4a levels in multiple sclerosis correlate with disease activity

B. Paul Morgan, Gillian Ingram, G. Ingram, 2010, Journal of Neuroimmunology.

A Novel Mutation in a Patient with a Deficiency of the Eighth Component of Complement Associated with Recurrent Meningococcal Meningitis

B. Ferry, H. Chapel, B. Morgan, 2009, Journal of Clinical Immunology.

Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.

Á. Szilágyi, Z. Prohászka, A. Szabó, 2016, Molecular immunology.

Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy

F. Baas, A. Geluk, V. Ramaglia, 2016, Clinical and experimental immunology.